Bio-Path Holdings, Inc.
BPTH
$0.03
-$0.01-19.53%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -77.45% | -56.74% | -39.75% | -9.51% | 4.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -53.30% | -30.52% | -11.97% | 0.15% | -19.01% |
| Operating Income | 53.30% | 30.52% | 11.97% | -0.15% | 19.01% |
| Income Before Tax | 36.47% | 12.33% | -6.33% | -6.21% | 31.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.47% | 12.33% | -6.33% | -6.21% | 31.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.47% | 12.33% | -6.33% | -6.21% | 31.32% |
| EBIT | 53.30% | 30.52% | 11.97% | -0.15% | 19.01% |
| EBITDA | 53.40% | 30.40% | 11.95% | -0.36% | 18.77% |
| EPS Basic | 74.91% | 85.05% | 86.03% | 87.17% | 89.40% |
| Normalized Basic EPS | 75.08% | 85.12% | 86.03% | 87.17% | 89.40% |
| EPS Diluted | 74.91% | 85.05% | 86.03% | 87.17% | 89.40% |
| Normalized Diluted EPS | 75.08% | 85.12% | 86.03% | 87.17% | 89.40% |
| Average Basic Shares Outstanding | 112.91% | 231.55% | 378.95% | 572.63% | 640.65% |
| Average Diluted Shares Outstanding | 112.91% | 231.55% | 378.95% | 572.63% | 640.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |